A phase 1b, randomized, double-blind, placebo-controlled, multiple-ascending dose study to investigate the safety, tolerability and pharmacokinetics of DSTA4637A in patients with Staphylococcus Aureus Bacteremia receiving standard-of-care antibiotics
Clinical Trial Grant
Administered By
Medicine, Infectious Diseases
Awarded By
Genentech, Inc.
Start Date
October 19, 2017
End Date
November 14, 2020
Administered By
Medicine, Infectious Diseases
Awarded By
Genentech, Inc.
Start Date
October 19, 2017
End Date
November 14, 2020